Results

Latest quarterly results

Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.

878 companies in Healthcare reported in the last 30 days · showing 551–600 · updated Wed, Nov 18, 2026

CompanySectorReportedQuarter RevenueRev. YoYNet incomeNI YoYEPSEPS YoY Op. marginMargin chg.Market cap
SPRYARS Pharmaceuticals, Inc. Healthcare Nov 5 Sep '26 $38.0M +15.2% −$36.0M n/m −$0.36 n/m -90.6% +73.0 pp $367M
CCCCC4 Therapeutics, Inc. Healthcare Nov 5 Sep '26 $8.0M −27.3% −$22.0M n/m −$0.16 n/m -290.5% +16.0 pp $332M
XFORX4 Pharmaceuticals, Inc. Healthcare Nov 5 Sep '26 $3.0M +50.0% −$20.0M n/m −$0.16 n/m -694.4% — $316M
ACBAurora Cannabis Inc. Healthcare Nov 5 Sep '26 $61.5M −4.4% — n/m $0.03 n/m -20.9% −0.6 pp $297M
INFUInfuSystems Holdings, Inc. Healthcare Nov 5 Sep '26 $38.0M +5.6% $3.0M +50.0% $0.15 +36.4% 12.6% +2.2 pp $296M
AGENAgenus Inc. Healthcare Nov 5 Sep '26 $31.0M +3.3% $3.0M −95.3% $0.02 −99.0% 36.2% +51.3 pp $281M
SABSSAB Biotherapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$22.0M −148.9% −$0.24 −141.4% — — $266M
PROFProfound Medical Corp. Healthcare Nov 5 Sep '26 $10.0M +100.0% −$8.0M n/m −$0.21 n/m -79.6% +89.0 pp $259M
ALLOAllogene Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$50.0M n/m −$0.15 n/m — — $258M
CAMPCAMP4 Therapeutics Corporation Healthcare Nov 5 Sep '26pending — — — — — — — — $251M
ARCTArcturus Therapeutics Holdings Inc. Healthcare Nov 5 Sep '26 $18.0M +5.9% −$7.0M n/m −$0.26 n/m -50.2% +46.1 pp $230M
KROSKeros Therapeutics, Inc. Healthcare Nov 5 Sep '26 $40.0M +185.7% $14.0M n/m $0.70 n/m 32.0% +139.9 pp $222M
CABACabaletta Bio, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$53.0M n/m −$0.28 n/m — — $220M
QSIQuantum-Si Incorporated Healthcare Nov 5 Sep '26 $0.0M −100.0% −$22.0M n/m −$0.10 n/m — — $202M
TRDAEntrada Therapeutics, Inc. Healthcare Nov 5 Sep '26 $1.0M −50.0% −$40.0M n/m −$0.94 n/m — — $194M
BIOABioAge Labs, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$34.0M n/m −$0.73 n/m — — $192M
RNACCartesian Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$11.0M n/m −$0.38 n/m — — $187M
PYXSPyxis Oncology, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$20.0M n/m −$0.24 n/m — — $172M
KRROKorro Bio, Inc. Healthcare Nov 5 Sep '26 $0.0M −100.0% −$18.0M n/m −$0.98 n/m — — $169M
KRSAKorsana Biosciences, Inc. Healthcare Nov 5 Sep '26 $0.0M −100.0% −$46.0M n/m −$343.24 n/m — — $152M
INGNInogen, Inc Healthcare Nov 5 Sep '26 $77.0M −16.3% −$16.0M n/m −$0.61 n/m -20.2% −12.5 pp $148M
DHDefinitive Healthcare Corp. Healthcare Nov 5 Sep '26 $55.0M −8.3% −$4.0M n/m −$0.04 n/m -9.1% +5.4 pp $140M
NTHINeOnc Technologies Holdings, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.28 n/m — — $125M
FATEFate Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$31.0M n/m −$0.25 n/m — — $119M
AKBAAkebia Therapeutics, Inc. Healthcare Nov 5 Sep '26 $37.0M −37.3% −$14.0M −1,500% −$0.05 n/m -31.1% −38.6 pp $111M
APYXApyx Medical Corporation Healthcare Nov 5 Sep '26 $14.0M +7.7% −$2.0M n/m −$0.04 n/m -4.1% +2.4 pp $108M
ORGOOrganogenesis Holdings Inc. - Class A Healthcare Nov 5 Sep '26 $45.0M −70.0% −$30.0M −236.4% −$0.25 −327.3% -64.9% −79.3 pp $105M
HCATHealth Catalyst, Inc Healthcare Nov 5 Sep '26 $56.0M −26.3% $40.0M n/m $0.53 n/m -28.0% −5.0 pp $104M
CCLDCareCloud, Inc. Healthcare Nov 5 Sep '26 $34.0M +9.7% $5.0M +66.7% $0.10 +150.0% 19.4% +9.1 pp $96M
VYGRVoyager Therapeutics, Inc. Healthcare Nov 5 Sep '26 $4.0M −69.2% −$25.0M n/m −$0.40 n/m -658.3% −429.3 pp $95M
NYXHNyxoah SA Healthcare Nov 5 Sep '26 $10.4M +350.0% — n/m −$0.20 n/m -238.5% — $92M
JYNTThe Joint Corp. Healthcare Nov 5 Sep '26 $14.0M +7.7% $0.0M −100.0% −$0.01 −116.7% 9.8% +8.6 pp $91M
SKINSkinHealth Systems Inc. Healthcare Nov 5 Sep '26 $69.0M −2.8% −$1.0M n/m −$0.14 n/m 7.2% +16.0 pp $90M
BDSXBiodesix, Inc. Healthcare Nov 5 Sep '26 $24.0M +9.1% −$8.0M n/m −$0.75 n/m -25.4% +6.9 pp $72M
VTVTvTv Therapeutics Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$12.0M n/m −$0.94 n/m — — $68M
CGTXCognition Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.04 n/m — — $60M
COCHEnvoy Medical, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.50 n/m — — $53M
RNXTRenovoRx, Inc. Healthcare Nov 5 Sep '26 $1.0M n/m −$4.0M n/m −$0.08 n/m -303.6% — $50M
ALDXAldeyra Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$4.0M n/m −$0.06 n/m — — $42M
DWTXDogwood Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$5.0M n/m −$0.14 n/m — — $41M
ELUTElutia, Inc. Healthcare Nov 5 Sep '26 $1.0M n/m −$1.0M n/m −$0.03 n/m -606.5% — $38M
TENXTenax Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$17.0M n/m −$0.31 n/m — — $38M
CRBUCaribou Biosciences, Inc. Healthcare Nov 5 Sep '26 $2.0M 0.0% −$27.0M n/m −$0.25 n/m — — $37M
NEPHNephros, Inc. Healthcare Nov 5 Sep '26 $6.0M +20.0% $1.0M n/m $0.05 +66.7% 8.9% +2.3 pp $32M
INMBINmune Bio Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$5.0M n/m −$0.17 n/m — — $30M
ELTXElicio Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$8.0M n/m −$0.30 n/m — — $27M
ACETAdicet Bio, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$19.0M n/m −$1.76 n/m — — $26M
FLNAFilana Therapeutics, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$11.0M n/m −$0.22 n/m — — $23M
SCYXSCYNEXIS, Inc. Healthcare Nov 5 Sep '26 $0.0M n/m −$8.0M n/m −$0.71 n/m — — $18M
LPCNLipocine Inc. Healthcare Nov 5 Sep '26 $2.0M n/m −$1.0M n/m −$0.08 n/m -37.9% — $18M
  • Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
  • YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
  • pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.